Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
for Breast Cancer
15 locations incl. Stamford
Sponsor: Dana-Farber Cancer Institute
Sex: All·Age: 18+
Code: NCT04468061·Phase 2·Recruiting·Listed Jul 2020
DFCI @ Foxborough
Clinical research site in Foxborough, Massachusetts · 10 LINCOLN RD, STE 101, FOXBOROUGH, MA 02035-1382 · (774) 215-5696
As of September 2026, 1 paid clinical trial is recruiting at DFCI @ Foxborough in Foxborough, Massachusetts. Active studies at this site cover conditions such as Breast Cancer, PD-L1 Negative and Triple Negative Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at DFCI @ Foxborough? We'll email you when one opens.
Recruiting clinical trials at DFCI @ Foxborough (1)
Get new-trial alerts for DFCI @ Foxborough
We'll email you whenever a new clinical trial starts recruiting at this research site in Foxborough, MA. Unsubscribe anytime.
More research sites in Foxborough
- Dana-Farber Cancer Institute at Foxborough (9 trials)
- K2 Medical Research - Foxborough (5 trials)
- Neurology Center of New England (3 trials)
- Dana-Farber Brigham Cancer Center - Foxborough (2 trials)
- Brigham and Women's Foxborough (1 trial)
- Brigham and Women's-Mass General Health Care Center (1 trial)
- Brigham and Womens/Mass General Health Care Center at Foxborough (1 trial)
- Center for Sports Performance and Research (1 trial)
- Clinical Study Site (1 trial)
- Dana Farber Cancer Institute at Foxborough (1 trial)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Foxborough, MA · Massachusetts clinical trials